However, the improvements in enthesitis with tofacitinib vs placebo in a study of patients with inadequate response to TNF inhibitors failed to achieve statistical significance [18], potentially suggesting that different JAK inhibitors may affect enthesitis to different extents. This evidence concerns the gene TNF and enthesitis.